Use of a mobile application for the control of anticoagulation with warfarin: a cluster randomized controlled clinical trial - Ijui/RS/Brazil
Braz. J. Pharm. Sci. (Online)
;
58: e19153, 2022. tab, graf
Artículo
en Inglés
| LILACS
| ID: biblio-1383960
ABSTRACT
Abstract To evaluate the effectiveness of an anticoagulation protocol adapted in a mobile application (appG) for patients using warfarin. This was a cluster randomized controlled clinical trial carried out in basic health centers of Ijui, RS, Brazil, between April and October 2017. The appG was installed on the cell phones of all physicians belonging to the intervention group. Primary outcomes were bleeding and thrombosis, and secondary outcomes were changes in the dose of warfarin, use of new drugs, drug interactions, search for health services, and remaining on the target international normalized ratio. Thirty-three patients belonging to 11 basic health centers were included in this study. From these, 15 patients were in the intervention group which used the appG, and 18 were in the control group. After 6 months, patients in the appG group had fewer bleeding events (7% versus 50%, p-value=0.028) and a lower weekly dose of warfarin (29.3 ± 9.7 mg versus 41.7 ± 12.5 mg, p-value=0.030) when compared to the control group. The anticoagulation protocol adapted in a mobile app reduced bleeding in patients using warfarin.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Médicos
/
Warfarina
/
Monitoreo Ambulatorio
/
Teléfono Celular
/
Aplicaciones Móviles
Tipo de estudio:
Ensayo Clínico Controlado
/
Guía de Práctica Clínica
País/Región como asunto:
America del Sur
/
Brasil
Idioma:
Inglés
Revista:
Braz. J. Pharm. Sci. (Online)
Asunto de la revista:
Farmacologia
/
Teraputica
/
Toxicologia
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Universidade Regional do Noroeste do Estado do Rio Grande do Sul/BR
Similares
MEDLINE
...
LILACS
LIS